Home > Boards > US Listed > Biotechs > BrainStorm Cell Therapeutics Inc. (BCLI)

We may have some news about MS entering

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Lorcan458 Member Profile
 
Followed By 0
Posts 55
Boards Moderated 0
Alias Born 09/14/16
160x600 placeholder
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 5/8/2020 12:05:34 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2020 6:32:09 AM
BrainStorm Announces Financial Results for the First Quarter of 2020 and Provides a Corporate Update GlobeNewswire Inc. - 5/7/2020 6:30:10 AM
BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn® for The European U... GlobeNewswire Inc. - 5/7/2020 1:00:10 AM
BrainStorm Presents New Data Highlighting NurOwn® Immunomodulation in Neurology GlobeNewswire Inc. - 5/4/2020 3:30:10 AM
BrainStorm-Cell Therapeutics to Announce First Quarter Financial Results and Provide a Corporate Update GlobeNewswire Inc. - 4/29/2020 6:00:10 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 4/8/2020 6:03:14 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 6:17:20 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/7/2020 6:16:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 6:15:05 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/7/2020 6:14:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 6:12:49 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/7/2020 6:12:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/3/2020 5:01:27 PM
BrainStorm Awarded $1.5 Million Non-Dilutive Grant for 2020 by the Israel Innovation Authority GlobeNewswire Inc. - 4/3/2020 6:59:09 AM
David Setboun Joins BrainStorm as Executive Vice President and Chief Operating Officer GlobeNewswire Inc. - 4/1/2020 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/31/2020 7:52:11 AM
BrainStorm Appoints Renowned Distinguished Economist, Prof. Jacob Frenkel, Chairman of the Board of Directors GlobeNewswire Inc. - 3/31/2020 4:00:10 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/18/2020 6:02:58 AM
BrainStorm to Hold a Conference Call to Update Investors on Corporate Steps Taken to Address COVID-19 GlobeNewswire Inc. - 3/16/2020 3:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/13/2020 5:02:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/13/2020 5:02:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/6/2020 5:07:47 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/6/2020 5:05:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/6/2020 4:11:33 PM
Lorcan458   Wednesday, 12/20/17 07:10:02 PM
Re: jfk post# 2412
Post # of 2683 
We may have some news about MS entering phase 1. They had a press release with some relatively famous reporter who took the MS treatment and there is video of his good results. Since Brainstorm is using the bodies own stem cells, and their proprietary incubation process allows customization of what the stem cells will produce (neurotrophic factors, etc.), it may be that the results of ALS testing will give more confidence on MS and vice-versa. If they end up having basically conquered all central nervous system diseases, this will be a huge win for humanity and for stockholders.

Of course, things could go the other way as well, but I haven't seen a single negative response from patients in any of the data I can find. Do your own research and let us know if you find anything (positive or negative). I'm more of a tech geek than medical guru, but from what I can tell by the graphs and charts from the other phases of testing, I'm building my share count.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist